127 related articles for article (PubMed ID: 25544575)
1. Breast Cancer-Related Lymphedema after Neoadjuvant Chemotherapy.
Kim M; Park IH; Lee KS; Ro J; Jung SY; Lee S; Kang HS; Lee ES; Kim TH; Cho KH; Shin KH
Cancer Res Treat; 2015 Jul; 47(3):416-23. PubMed ID: 25544575
[TBL] [Abstract][Full Text] [Related]
2. A model to estimate the risk of breast cancer-related lymphedema: combinations of treatment-related factors of the number of dissected axillary nodes, adjuvant chemotherapy, and radiation therapy.
Kim M; Kim SW; Lee SU; Lee NK; Jung SY; Kim TH; Lee ES; Kang HS; Shin KH
Int J Radiat Oncol Biol Phys; 2013 Jul; 86(3):498-503. PubMed ID: 23541809
[TBL] [Abstract][Full Text] [Related]
3. Treatment factors affecting breast cancer-related lymphedema after systemic chemotherapy and radiotherapy in stage II/III breast cancer patients.
Jung SY; Shin KH; Kim M; Chung SH; Lee S; Kang HS; Lee ES; Kwon Y; Lee KS; Park IH; Ro J
Breast Cancer Res Treat; 2014 Nov; 148(1):91-8. PubMed ID: 25253173
[TBL] [Abstract][Full Text] [Related]
4. Obesity is a risk factor for developing postoperative lymphedema in breast cancer patients.
Helyer LK; Varnic M; Le LW; Leong W; McCready D
Breast J; 2010; 16(1):48-54. PubMed ID: 19889169
[TBL] [Abstract][Full Text] [Related]
5. Residual lymph node disease after neoadjuvant chemotherapy predicts an increased risk of lymphedema in node-positive breast cancer patients.
Specht MC; Miller CL; Skolny MN; Jammallo LS; O'Toole J; Horick N; Isakoff SJ; Smith BL; Taghian AG
Ann Surg Oncol; 2013 Sep; 20(9):2835-41. PubMed ID: 23689935
[TBL] [Abstract][Full Text] [Related]
6. The influence of axillary reverse mapping related factors on lymphedema in breast cancer patients.
Ikeda K; Ogawa Y; Kajino C; Deguchi S; Kurihara S; Tashima T; Goto W; Nishiguchi Y; Tokunaga S; Fukushima H; Inoue T
Eur J Surg Oncol; 2014 Jul; 40(7):818-23. PubMed ID: 24768416
[TBL] [Abstract][Full Text] [Related]
7. Axillary-conserving surgery is facilitated by neoadjuvant chemotherapy of breast cancer.
Beatty JD; Precht LM; Lowe K; Atwood M
Am J Surg; 2009 May; 197(5):637-41; discussion 641-2. PubMed ID: 19321159
[TBL] [Abstract][Full Text] [Related]
8. Nomograms for predicting the risk of arm lymphedema after axillary dissection in breast cancer.
Bevilacqua JL; Kattan MW; Changhong Y; Koifman S; Mattos IE; Koifman RJ; Bergmann A
Ann Surg Oncol; 2012 Aug; 19(8):2580-9. PubMed ID: 22395997
[TBL] [Abstract][Full Text] [Related]
9. Does axillary boost increase lymphedema compared with supraclavicular radiation alone after breast conservation?
Hayes SB; Freedman GM; Li T; Anderson PR; Ross E
Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1449-55. PubMed ID: 19028274
[TBL] [Abstract][Full Text] [Related]
10. Identification of Prognostic Risk Factors for Transient and Persistent Lymphedema after Multimodal Treatment for Breast Cancer.
Kim M; Shin KH; Jung SY; Lee S; Kang HS; Lee ES; Chung SH; Kim YJ; Kim TH; Cho KH
Cancer Res Treat; 2016 Oct; 48(4):1330-1337. PubMed ID: 26875199
[TBL] [Abstract][Full Text] [Related]
11. The importance of detection of subclinical lymphedema for the prevention of breast cancer-related clinical lymphedema after axillary lymph node dissection; a prospective observational study.
Soran A; Ozmen T; McGuire KP; Diego EJ; McAuliffe PF; Bonaventura M; Ahrendt GM; DeGore L; Johnson R
Lymphat Res Biol; 2014 Dec; 12(4):289-94. PubMed ID: 25495384
[TBL] [Abstract][Full Text] [Related]
12. Lymphedema following breast cancer treatment, including sentinel lymph node biopsy.
Armer J; Fu MR; Wainstock JM; Zagar E; Jacobs LK
Lymphology; 2004 Jun; 37(2):73-91. PubMed ID: 15328760
[TBL] [Abstract][Full Text] [Related]
13. Radiation therapy risk factors for development of lymphedema in patients treated with regional lymph node irradiation for breast cancer.
Chandra RA; Miller CL; Skolny MN; Warren LE; Horick N; Jammallo LS; Sadek BT; Shenouda MN; O'Toole J; Specht MC; Taghian AG
Int J Radiat Oncol Biol Phys; 2015 Mar; 91(4):760-4. PubMed ID: 25752389
[TBL] [Abstract][Full Text] [Related]
14. Risk of Lymphedema and Death after Lymph Node Dissection with Neoadjuvant and Adjuvant Treatments in Patients with Breast Cancer: An Eight-Year Nationwide Cohort Study.
Lee YS; Lim YC; Yeo J; Kim SY; Lee YJ; Ha IH
Healthcare (Basel); 2023 Jun; 11(13):. PubMed ID: 37444667
[TBL] [Abstract][Full Text] [Related]
15. The incidence and risk factors for occurrence of arm lymphedema after treatment of breast cancer.
Rebegea L; Firescu D; Dumitru M; Anghel R
Chirurgia (Bucur); 2015; 110(1):33-7. PubMed ID: 25800313
[TBL] [Abstract][Full Text] [Related]
16. Level III axillary lymph nodes involvement in node positive breast cancer received neoadjuvant chemotherapy.
Fan Z; Li J; Wang T; Xie Y; Fan T; Lin B; Ouyang T
Breast; 2013 Dec; 22(6):1161-5. PubMed ID: 24080493
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of axillary nodal ratio in stage II/III breast cancer treated with neoadjuvant chemotherapy.
Keam B; Im SA; Kim HJ; Oh DY; Kim JH; Lee SH; Chie EK; Han W; Kim DW; Cho N; Moon WK; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
Breast Cancer Res Treat; 2009 Jul; 116(1):153-60. PubMed ID: 18787948
[TBL] [Abstract][Full Text] [Related]
18. Supraclavicular radiation for breast cancer does not increase the 10-year risk of stroke.
Woodward WA; Giordano SH; Duan Z; Hortobagyi GN; Buchholz TA
Cancer; 2006 Jun; 106(12):2556-62. PubMed ID: 16691617
[TBL] [Abstract][Full Text] [Related]
19. Lymph node counts and ratio in axillary dissections following neoadjuvant chemotherapy for breast cancer: a better alternative to traditional pN staging.
Chen S; Liu Y; Huang L; Chen CM; Wu J; Shao ZM
Ann Surg Oncol; 2014 Jan; 21(1):42-50. PubMed ID: 24013900
[TBL] [Abstract][Full Text] [Related]
20. Determining which patients require irradiation of the supraclavicular nodal area after surgery for N1 breast cancer.
Yu JI; Park W; Huh SJ; Choi DH; Lim YH; Ahn JS; Yang JH; Nam SJ
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1135-41. PubMed ID: 20231065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
